content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
    <headerData>
      <submissionType>144</submissionType>
      <filerInfo>
        <filer>
          <filerCredentials>
            <cik>0001190636</cik>
            <ccc>XXXXXXXX</ccc>
          </filerCredentials>
        </filer>
        <liveTestFlag>LIVE</liveTestFlag>
  
  
  
      </filerInfo>
    </headerData>
    <formData>
      <issuerInfo>
        <issuerCik>0001531048</issuerCik>
        <issuerName>Inari Medical, Inc.</issuerName>
        <secFileNumber>001-39293</secFileNumber>
        <issuerAddress>
          <com:street1>6001 OAK CANYON, SUITE 100</com:street1>
          <com:city>IRVINE</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>92618</com:zipCode>
        </issuerAddress>
        <issuerContactPhone>949-923-4747</issuerContactPhone>
        <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>KRAUSZ STEVEN M</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
        <relationshipsToIssuer>
          <relationshipToIssuer>Venture Capital Investor/General Partner at USVP</relationshipToIssuer>
        </relationshipsToIssuer>
      </issuerInfo>
      <securitiesInformation>
        <securitiesClassTitle>Inari Medical, Inc.</securitiesClassTitle>
        <brokerOrMarketmakerDetails>
          <name>Merrill Lynch - Venture Services Group</name>
          <address>
            <com:street1>555 California St</com:street1>
            <com:street2>Floor 18</com:street2>
            <com:city>San Francisco</com:city>
            <com:stateOrCountry>CA</com:stateOrCountry>
            <com:zipCode>94104</com:zipCode>
          </address>
        </brokerOrMarketmakerDetails>
        <noOfUnitsSold>6459</noOfUnitsSold>
        <aggregateMarketValue>432753.00</aggregateMarketValue>
        <noOfUnitsOutstanding>57172042</noOfUnitsOutstanding>
        <approxSaleDate>05/18/2023</approxSaleDate>
        <securitiesExchangeName>NASDAQ</securitiesExchangeName>
      </securitiesInformation>
      <securitiesToBeSold>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <acquiredDate>09/26/2020</acquiredDate>
        <natureOfAcquisitionTransaction>Private placement and subsequent in-kind distribution from USVP</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>6459</amountOfSecuritiesAcquired>
        <paymentDate>09/26/2020</paymentDate>
        <natureOfPayment>Private Placement</natureOfPayment>
      </securitiesToBeSold>
      <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
      <noticeSignature>
        <noticeDate>05/18/2023</noticeDate>
        <signature>Steven Krausz</signature>
      </noticeSignature>
    </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 2876}]
text: 144
  0001190636
  XXXXXXXX
  LIVE
  0001531048
  Inari Medical, Inc.
  001-39293
  6001 OAK CANYON, SUITE 100
  IRVINE
  CA
  92618
  949-923-4747
  KRAUSZ STEVEN M
  Venture Capital Investor/General Partner at USVP
  Inari Medical, Inc.
  Merrill Lynch - Venture Services Group
  555 California St
  Floor 18
  San Francisco
  CA
  94104
  6459
  432753.00
  57172042
  05/18/2023
  NASDAQ
  Common
  09/26/2020
  Private placement and subsequent in-kind distribution from USVP
  Issuer
  N
  6459
  09/26/2020
  Private Placement
  Y
  05/18/2023
  Steven Krausz